Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Advanced Breast Cancer
Interventions: PROCEDURE: specimen sample collection
Sponsor: Centre Oscar Lambret
Collaborators: Laboratoire PRISM - Michel SALZET